Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2008

Open Access 01-12-2008 | Research article

Autoadjusting-CPAP effect on serum Leptin concentrations in Obstructive Sleep Apnoea patients

Authors: Marta Drummond, João C Winck, João T Guimarães, Ana C Santos, João Almeida, José A Marques

Published in: BMC Pulmonary Medicine | Issue 1/2008

Login to get access

Abstract

Background

Leptin is an hormone that regulates body weight. Studies have shown increasing leptin concentrations according to body mass index (BMI) and intermittent hypoxia.
Our aim is to evaluate the basal leptin levels in OSA patients and its possible relation to OSA severity, independently of confounders and investigate the Autoadjusting-CPAP effect on leptin values.

Methods

In ninety eight male patients with moderate to severe OSA leptin serum levels were evaluated before therapy, 9 days and 6 months after therapy.

Results

In this group mean age was 55.3 years, mean BMI was 33.2 Kg/m2 and mean Apnoea- Hypopnea Index (AHI) was 51.7/h. Mean basal serum leptin value was 12.1 ug/L. Univariate analysis showed a significant correlation between serum leptin values and BMI (R = 0.68; p < 0.001), waist-hip ratio (R = 0.283; p = 0.004) and AHI (R = 0.198; p = 0.048); in stepwise multiple regression analysis only BMI (p < 0.001) was a predictor of serum leptin values.
One week after therapy, mean leptin serum level decreased to 11.0 ug/L and 6 months after it was 11.4 ug/L. (p = 0.56 and p = 0.387, respectively)

Conclusion

Baseline leptin serum levels positively correlate with BMI, fat distributioand OSA severity.
BMI is the only predictor of basal leptin levels.
Treatment with Autoadjusting-CPAP has a small effect on leptin levels.
Literature
1.
go back to reference Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S: The occurrence of Sleep-Disordered Breathing among middle-aged adults. N Engl J Med. 1993, 328: 1230-1235. 10.1056/NEJM199304293281704.CrossRefPubMed Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S: The occurrence of Sleep-Disordered Breathing among middle-aged adults. N Engl J Med. 1993, 328: 1230-1235. 10.1056/NEJM199304293281704.CrossRefPubMed
2.
go back to reference Vgontzas NA, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A: Sleep apnea and sleep disruption in obese patients. Arch Intern Med. 1994, 154: 1705-1711. 10.1001/archinte.154.15.1705.CrossRefPubMed Vgontzas NA, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A: Sleep apnea and sleep disruption in obese patients. Arch Intern Med. 1994, 154: 1705-1711. 10.1001/archinte.154.15.1705.CrossRefPubMed
3.
go back to reference Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottlieb DJ, Walsleben JA, Finn L, Enright P, Samet JM: Predictors of sleep-disordered breathing in community-dwelling adults. Arch Intern Med. 2002, 162 (8): 893-900. 10.1001/archinte.162.8.893.CrossRefPubMed Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottlieb DJ, Walsleben JA, Finn L, Enright P, Samet JM: Predictors of sleep-disordered breathing in community-dwelling adults. Arch Intern Med. 2002, 162 (8): 893-900. 10.1001/archinte.162.8.893.CrossRefPubMed
4.
go back to reference van Boxem TJM, de Groot GH: Prevalence and severity of sleep disordered breathing in a group of morbidly obese patients. Neth J Med. 1999, 54 (5): 202-206. 10.1016/S0300-2977(98)00139-9.CrossRefPubMed van Boxem TJM, de Groot GH: Prevalence and severity of sleep disordered breathing in a group of morbidly obese patients. Neth J Med. 1999, 54 (5): 202-206. 10.1016/S0300-2977(98)00139-9.CrossRefPubMed
5.
go back to reference Richman RM, Elliott LM, Burns CM, Bearpark HM, Steinbeck KS, Caterson ID: The prevalence of obstructive sleep apnoea in an obese female population. Int J Obes Relat Metab Disord. 1994, 18 (3): 173-177.PubMed Richman RM, Elliott LM, Burns CM, Bearpark HM, Steinbeck KS, Caterson ID: The prevalence of obstructive sleep apnoea in an obese female population. Int J Obes Relat Metab Disord. 1994, 18 (3): 173-177.PubMed
6.
go back to reference Resta O, Foschino-Barbaro MP, Legari G, Talamo S, Bonfitto P, Palumbo A, Minenna A, Giorgino R, Pergola GD: Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord. 2001, 25 (5): 669-675. 10.1038/sj.ijo.0801603.CrossRefPubMed Resta O, Foschino-Barbaro MP, Legari G, Talamo S, Bonfitto P, Palumbo A, Minenna A, Giorgino R, Pergola GD: Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord. 2001, 25 (5): 669-675. 10.1038/sj.ijo.0801603.CrossRefPubMed
7.
go back to reference Malhotra Atul, White David: Obstructive sleep apnoea. Lancet. 2002, 360 (9328): 237-245. 10.1016/S0140-6736(02)09464-3.CrossRefPubMed Malhotra Atul, White David: Obstructive sleep apnoea. Lancet. 2002, 360 (9328): 237-245. 10.1016/S0140-6736(02)09464-3.CrossRefPubMed
8.
go back to reference Gami AS, Caples SM, Somers VK: Obesity and obstructive sleep apnea. Endocrinol Metab Clin N Am. 2003, 32: 869-894. 10.1016/S0889-8529(03)00069-0.CrossRef Gami AS, Caples SM, Somers VK: Obesity and obstructive sleep apnea. Endocrinol Metab Clin N Am. 2003, 32: 869-894. 10.1016/S0889-8529(03)00069-0.CrossRef
9.
go back to reference Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997, 100: 270-278. 10.1172/JCI119532.CrossRefPubMedPubMedCentral Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997, 100: 270-278. 10.1172/JCI119532.CrossRefPubMedPubMedCentral
10.
go back to reference Lima J: Leptin and neuroendocrinology. Arqui Med. 2002, 16 (2): 115-120. Lima J: Leptin and neuroendocrinology. Arqui Med. 2002, 16 (2): 115-120.
11.
go back to reference Marik PE: Leptin, obesity, and obstructive sleep apnea. Chest. 2000, 118 (3): 569-571. 10.1378/chest.118.3.569.CrossRefPubMed Marik PE: Leptin, obesity, and obstructive sleep apnea. Chest. 2000, 118 (3): 569-571. 10.1378/chest.118.3.569.CrossRefPubMed
12.
go back to reference Patel SR, Palmer LJ, Larkin EK, Jenny NS, White DP, Redline SMD: Relationship between obstructive sleep apnea and diurnal leptin rhythms. Sleep. 2004, 27 (2): 235-239.PubMed Patel SR, Palmer LJ, Larkin EK, Jenny NS, White DP, Redline SMD: Relationship between obstructive sleep apnea and diurnal leptin rhythms. Sleep. 2004, 27 (2): 235-239.PubMed
13.
go back to reference Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B: Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci. 1998, 1881: 559-572. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B: Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci. 1998, 1881: 559-572.
14.
go back to reference Auwerx J, Staels B: Leptin. The Lancet. 1998, 351: 737-742. 10.1016/S0140-6736(97)06348-4.CrossRef Auwerx J, Staels B: Leptin. The Lancet. 1998, 351: 737-742. 10.1016/S0140-6736(97)06348-4.CrossRef
15.
go back to reference Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, Mackellar W, Rosteck PR, Schoner B, Smith D, Tinsley FC, Zhang XY, Heiman M: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995, 377: 530-532. 10.1038/377530a0.CrossRefPubMed Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, Mackellar W, Rosteck PR, Schoner B, Smith D, Tinsley FC, Zhang XY, Heiman M: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995, 377: 530-532. 10.1038/377530a0.CrossRefPubMed
16.
go back to reference Erickson JC, Hollopeter G, Palmiter RD: Attenuation of the obesity syndrome of the ob/ob mice by the loss of neuropeptide Y. Science. 1996, 274: 1704-1707. 10.1126/science.274.5293.1704.CrossRefPubMed Erickson JC, Hollopeter G, Palmiter RD: Attenuation of the obesity syndrome of the ob/ob mice by the loss of neuropeptide Y. Science. 1996, 274: 1704-1707. 10.1126/science.274.5293.1704.CrossRefPubMed
17.
go back to reference Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS: Role of leptin in fat regulation. Nature. 1996, 380: 677-10.1038/380677a0.CrossRefPubMed Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS: Role of leptin in fat regulation. Nature. 1996, 380: 677-10.1038/380677a0.CrossRefPubMed
18.
go back to reference Rubinsztajn R, Kumor M, Byskiniewicz K, Bielicki P, Chazan R: Serum leptin concentration and sympathetic activation estimated on the adrenalin and noradrenalin serum concentration in patients with obstructive sleep apnea. Pol Arch Med Wewn. 2005, 113 (6): 544-551.PubMed Rubinsztajn R, Kumor M, Byskiniewicz K, Bielicki P, Chazan R: Serum leptin concentration and sympathetic activation estimated on the adrenalin and noradrenalin serum concentration in patients with obstructive sleep apnea. Pol Arch Med Wewn. 2005, 113 (6): 544-551.PubMed
19.
go back to reference Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995, 269: 540-543. 10.1126/science.7624776.CrossRefPubMed Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995, 269: 540-543. 10.1126/science.7624776.CrossRefPubMed
20.
go back to reference Haalas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effectsof the plasma protein encoded by the obese gene. Science. 1995, 269: 543-546. 10.1126/science.7624777.CrossRef Haalas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effectsof the plasma protein encoded by the obese gene. Science. 1995, 269: 543-546. 10.1126/science.7624777.CrossRef
21.
go back to reference O'Donnell CP, Tankersley CG, Polotsky VP, Schwartz AR, Smith PL: Leptin, obesity, and respiratory function. Respir Physiol. 2000, 119 (2–3): 163-170. 10.1016/S0034-5687(99)00111-5.CrossRefPubMed O'Donnell CP, Tankersley CG, Polotsky VP, Schwartz AR, Smith PL: Leptin, obesity, and respiratory function. Respir Physiol. 2000, 119 (2–3): 163-170. 10.1016/S0034-5687(99)00111-5.CrossRefPubMed
22.
go back to reference Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature. 1998, 395: 763-770. 10.1038/27376.CrossRefPubMed Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature. 1998, 395: 763-770. 10.1038/27376.CrossRefPubMed
23.
go back to reference Ostlund RE, Yang JW, Klein S, Gingerich R: Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab. 2005, 81 (11): 3909-3913. 10.1210/jc.81.11.3909. Ostlund RE, Yang JW, Klein S, Gingerich R: Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab. 2005, 81 (11): 3909-3913. 10.1210/jc.81.11.3909.
24.
go back to reference Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kin S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine. 1995, 1: 1155-1161. 10.1038/nm1195-1155.CrossRefPubMed Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kin S, Lallone R, Ranganathan S, Kern PA, Friedman JM: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine. 1995, 1: 1155-1161. 10.1038/nm1195-1155.CrossRefPubMed
25.
go back to reference Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohanneslan JP, Marco CC, Mkee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996, 334: 292-295. 10.1056/NEJM199602013340503.CrossRefPubMed Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohanneslan JP, Marco CC, Mkee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996, 334: 292-295. 10.1056/NEJM199602013340503.CrossRefPubMed
26.
go back to reference Jin G, Wang W, Kang J, Wu Y, Hou X, Yu R: Study of serum leptin level in patients with obstructive sleep apnea. Zhonghua Jie He He Hu Xi Za Zhi. 2002, 25 (4): 204-206.PubMed Jin G, Wang W, Kang J, Wu Y, Hou X, Yu R: Study of serum leptin level in patients with obstructive sleep apnea. Zhonghua Jie He He Hu Xi Za Zhi. 2002, 25 (4): 204-206.PubMed
27.
go back to reference Manzella D, Parillo M, Razzino T, Gnasso P, Buonanno S, Gargiulo A, Caputi M, Paolisso G: Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Int J Obes Relat Metab Disord. 2002, 26 (3): 370-5. 10.1038/sj.ijo.0801939.CrossRefPubMed Manzella D, Parillo M, Razzino T, Gnasso P, Buonanno S, Gargiulo A, Caputi M, Paolisso G: Soluble leptin receptor and insulin resistance as determinant of sleep apnea. Int J Obes Relat Metab Disord. 2002, 26 (3): 370-5. 10.1038/sj.ijo.0801939.CrossRefPubMed
28.
go back to reference Ozturk L, Ünal M, Tamer L, Celikoglu F: The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg. 2003, 129 (5): 538-540. 10.1001/archotol.129.5.538.CrossRefPubMed Ozturk L, Ünal M, Tamer L, Celikoglu F: The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg. 2003, 129 (5): 538-540. 10.1001/archotol.129.5.538.CrossRefPubMed
29.
go back to reference Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK: Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol. 2000, 279 (1): H234-237.PubMed Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK: Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol. 2000, 279 (1): H234-237.PubMed
30.
go back to reference Ciftci TU, Kokturk O, Bukan N, Bilgihan A: Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome. Respiration. 2005, 72 (4): 395-401. 10.1159/000086254.CrossRef Ciftci TU, Kokturk O, Bukan N, Bilgihan A: Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome. Respiration. 2005, 72 (4): 395-401. 10.1159/000086254.CrossRef
31.
go back to reference Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP: Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000, 85: 1151-1158. 10.1210/jc.85.3.1151.CrossRefPubMed Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP: Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000, 85: 1151-1158. 10.1210/jc.85.3.1151.CrossRefPubMed
32.
go back to reference Ip MS, Lam KS, Ho C, Tsang KW, Lam W: Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000, 118: 580-586. 10.1378/chest.118.3.580.CrossRefPubMed Ip MS, Lam KS, Ho C, Tsang KW, Lam W: Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000, 118: 580-586. 10.1378/chest.118.3.580.CrossRefPubMed
33.
go back to reference Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK: Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest. 2002, 122 (3): 829-839. 10.1378/chest.122.3.829.CrossRefPubMed Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK: Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest. 2002, 122 (3): 829-839. 10.1378/chest.122.3.829.CrossRefPubMed
34.
go back to reference Barceló A, Barbé F, Llompart E, de la Peña M, Durán-Cantolla J, Ladaria A, Bosch M, Guerra L, Agustí AG: Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome. Am J respir Crit Care Med. 2005, 171 (2): 183-187. 10.1164/rccm.200405-579OC.CrossRefPubMed Barceló A, Barbé F, Llompart E, de la Peña M, Durán-Cantolla J, Ladaria A, Bosch M, Guerra L, Agustí AG: Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome. Am J respir Crit Care Med. 2005, 171 (2): 183-187. 10.1164/rccm.200405-579OC.CrossRefPubMed
35.
go back to reference Tankersley CG, O'Donnell C, Daood MJ, Watchko JF, Mitzner W, Schwartz A, Smith P: Leptin attenuates respiratory complications associated with the obese phenotype. J Appl Physiol. 1998, 85: 2261-2269.PubMed Tankersley CG, O'Donnell C, Daood MJ, Watchko JF, Mitzner W, Schwartz A, Smith P: Leptin attenuates respiratory complications associated with the obese phenotype. J Appl Physiol. 1998, 85: 2261-2269.PubMed
36.
go back to reference O'Donnell CP, Schaub CD, Haines AS, Berkowitz DE, Tankersley CG, Schwartz AR, Smith PL: Leptin prevents respiratory depression in obesity. Am J respir Crit Care Med. 1999, 159: 1477-1484.CrossRefPubMed O'Donnell CP, Schaub CD, Haines AS, Berkowitz DE, Tankersley CG, Schwartz AR, Smith PL: Leptin prevents respiratory depression in obesity. Am J respir Crit Care Med. 1999, 159: 1477-1484.CrossRefPubMed
37.
go back to reference Harsch I, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Pour Schahin S, Wiest GH, Hahn EG, Lohmann T, Ficker JH: Leptin and ghrelin levels in patients with obstructive seep apnoea: effect of CPAP treatment. Eur Respir J. 2003, 22 (2): 251-257. 10.1183/09031936.03.00010103.CrossRefPubMed Harsch I, Konturek PC, Koebnick C, Kuehnlein PP, Fuchs FS, Pour Schahin S, Wiest GH, Hahn EG, Lohmann T, Ficker JH: Leptin and ghrelin levels in patients with obstructive seep apnoea: effect of CPAP treatment. Eur Respir J. 2003, 22 (2): 251-257. 10.1183/09031936.03.00010103.CrossRefPubMed
38.
go back to reference Huang R, Huang XZ, Wang HG, Li M, Xiao Y: Effects of nasal continuous positive airway pressure on serum leptin concentration and the metabolic parameters in obstructive sleep apnea hypopnea syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004, 26 (2): 168-171.PubMed Huang R, Huang XZ, Wang HG, Li M, Xiao Y: Effects of nasal continuous positive airway pressure on serum leptin concentration and the metabolic parameters in obstructive sleep apnea hypopnea syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004, 26 (2): 168-171.PubMed
39.
go back to reference Sanner BM, Kollhosser P, Buechner N, Zidek W, Tepel M: Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir. 2004, 23 (4): 601-604. 10.1183/09031936.04.00067804.CrossRef Sanner BM, Kollhosser P, Buechner N, Zidek W, Tepel M: Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir. 2004, 23 (4): 601-604. 10.1183/09031936.04.00067804.CrossRef
40.
go back to reference Shimizu K, Chin K, Nakamura T, Masuzaki H, Ogawa Y, Hosokawa R, Niimi A, Hattori N, Nohara R, Sasayama S, Nakao K, Mishima M, Nakamura T, Ohi M: Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax. 2002, 57 (5): 429-434. 10.1136/thorax.57.5.429.CrossRefPubMedPubMedCentral Shimizu K, Chin K, Nakamura T, Masuzaki H, Ogawa Y, Hosokawa R, Niimi A, Hattori N, Nohara R, Sasayama S, Nakao K, Mishima M, Nakamura T, Ohi M: Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax. 2002, 57 (5): 429-434. 10.1136/thorax.57.5.429.CrossRefPubMedPubMedCentral
41.
go back to reference Tharaux PL: Effect of sleep apnea syndrome on the vascular endothelium. Rev Neurol. 2003, 159 (11): 6s102-106.PubMed Tharaux PL: Effect of sleep apnea syndrome on the vascular endothelium. Rev Neurol. 2003, 159 (11): 6s102-106.PubMed
42.
go back to reference The report of an American Academy of Sleep Medicine Task Force: Sleep- related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999, 22 (5): 667-689. The report of an American Academy of Sleep Medicine Task Force: Sleep- related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999, 22 (5): 667-689.
43.
go back to reference Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M: Radioimmunoassay of leptin in human plasma. Clin Chem. 1996, 42: 942-946.PubMed Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M: Radioimmunoassay of leptin in human plasma. Clin Chem. 1996, 42: 942-946.PubMed
44.
go back to reference Bray GA: Pathophysiology of obesity. Am J Clin Nutr. 1992, 55: 4883-4943. Bray GA: Pathophysiology of obesity. Am J Clin Nutr. 1992, 55: 4883-4943.
45.
go back to reference Mantzoros CS: The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med. 1999, 130: 671-680.CrossRefPubMed Mantzoros CS: The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med. 1999, 130: 671-680.CrossRefPubMed
46.
go back to reference Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, Leibel RL: Effects of gender, body composition, and menopause on plasma concenrations of leptin. J Clin Endocrinol Metab. 1996, 81: 3424-3427. 10.1210/jc.81.9.3424.PubMed Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, Leibel RL: Effects of gender, body composition, and menopause on plasma concenrations of leptin. J Clin Endocrinol Metab. 1996, 81: 3424-3427. 10.1210/jc.81.9.3424.PubMed
47.
go back to reference Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T: Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest. 2005, 127: 716-721. 10.1378/chest.127.3.716.CrossRefPubMed Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T: Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest. 2005, 127: 716-721. 10.1378/chest.127.3.716.CrossRefPubMed
48.
go back to reference Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakamura T, Nakao K, Ohi M: Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea sydrome following nasal continuous positive airway pressure therapy. Circulation. 1999, 100: 706-712.CrossRefPubMed Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakamura T, Nakao K, Ohi M: Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea sydrome following nasal continuous positive airway pressure therapy. Circulation. 1999, 100: 706-712.CrossRefPubMed
49.
go back to reference Massie CA, McArdle N, Hart RW, Schmidt-Nowara WW, Lankford A, Hudgel DW, Gordon N, Douglas NJ: Comparison between automatic and fixed positive airway pressure therapy in the home. Am J Respir Crit Care Med. 2003, 167: 20-23. 10.1164/rccm.200201-022OC.CrossRefPubMed Massie CA, McArdle N, Hart RW, Schmidt-Nowara WW, Lankford A, Hudgel DW, Gordon N, Douglas NJ: Comparison between automatic and fixed positive airway pressure therapy in the home. Am J Respir Crit Care Med. 2003, 167: 20-23. 10.1164/rccm.200201-022OC.CrossRefPubMed
50.
go back to reference Ayas NT, Patel SR, Malhotra A, Schulzer M, Malhotra M, Jung D, Fleetham J, White DP: Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: Results of a meta-analysis. Sleep. 2004, 27: 249-253.PubMed Ayas NT, Patel SR, Malhotra A, Schulzer M, Malhotra M, Jung D, Fleetham J, White DP: Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: Results of a meta-analysis. Sleep. 2004, 27: 249-253.PubMed
51.
go back to reference Behbehani K, Yen FC, Lucas EA, Burk JR: A sleep laboratory evaluation of an automatic positive airway pressure system for treatment of obstructive sleep apnea. Sleep. 1998, 21: 485-491.PubMed Behbehani K, Yen FC, Lucas EA, Burk JR: A sleep laboratory evaluation of an automatic positive airway pressure system for treatment of obstructive sleep apnea. Sleep. 1998, 21: 485-491.PubMed
52.
go back to reference Teschler H, Wessendorf TE, Farhat AA, Konietzko N, Berthon-Jones M: Two months auto-adjusting versus conventional nCPAP for obstructive sleep apnoea syndrome. Eur Respir J. 2000, 15: 990-995. 10.1034/j.1399-3003.2000.01503.x.CrossRefPubMed Teschler H, Wessendorf TE, Farhat AA, Konietzko N, Berthon-Jones M: Two months auto-adjusting versus conventional nCPAP for obstructive sleep apnoea syndrome. Eur Respir J. 2000, 15: 990-995. 10.1034/j.1399-3003.2000.01503.x.CrossRefPubMed
53.
go back to reference d'Ortho MP, Grillier-Lanoir V, Levy P, Goldenberg F, Corriger E, Harf A, Lofaso F: Constant vs automatic continuous positive airway pressure therapy: home evaluation. Chest. 2000, 118: 1010-1017. 10.1378/chest.118.4.1010.CrossRefPubMed d'Ortho MP, Grillier-Lanoir V, Levy P, Goldenberg F, Corriger E, Harf A, Lofaso F: Constant vs automatic continuous positive airway pressure therapy: home evaluation. Chest. 2000, 118: 1010-1017. 10.1378/chest.118.4.1010.CrossRefPubMed
54.
go back to reference Noseda A, Kempenaers C, Kerkhofs M, Braun S, Linkowski P, Jann E: Constant vs auto-continuous positive airway pressure in patients with sleep apnea hypopnea syndrome and a high variability in pressure requirement. Chest. 2004, 126: 31-37. 10.1378/chest.126.1.31.CrossRefPubMed Noseda A, Kempenaers C, Kerkhofs M, Braun S, Linkowski P, Jann E: Constant vs auto-continuous positive airway pressure in patients with sleep apnea hypopnea syndrome and a high variability in pressure requirement. Chest. 2004, 126: 31-37. 10.1378/chest.126.1.31.CrossRefPubMed
55.
go back to reference Marrone O, Insalaco G, Bonsignore MR, Romano S, Salvaggio A, Bonsignore G: Sleep structure correlates of continuous positive airway pressure variations during application of an autotitrating continuous positive airway pressure machine in patients with obstructive sleep apnea syndrome. Chest. 2002, 121: 759-767. 10.1378/chest.121.3.759.CrossRefPubMed Marrone O, Insalaco G, Bonsignore MR, Romano S, Salvaggio A, Bonsignore G: Sleep structure correlates of continuous positive airway pressure variations during application of an autotitrating continuous positive airway pressure machine in patients with obstructive sleep apnea syndrome. Chest. 2002, 121: 759-767. 10.1378/chest.121.3.759.CrossRefPubMed
56.
go back to reference Golpe R, Jiménez A, Carpizo R: Home sleep studies in the assessment of sleep apnea/hypopnea syndrome. Chest. 2002, 122: 1156-1161. 10.1378/chest.122.4.1156.CrossRefPubMed Golpe R, Jiménez A, Carpizo R: Home sleep studies in the assessment of sleep apnea/hypopnea syndrome. Chest. 2002, 122: 1156-1161. 10.1378/chest.122.4.1156.CrossRefPubMed
57.
go back to reference Dingli K, Coleman EL, Nennelle M, Finch SP, Wraith PK, Mackay TW, Douglas NJ: Evaluation of a portable device for diagnosing the sleep apnea/hypopnoea syndrome. Eur respir J. 2003, 21: 253-259. 10.1183/09031936.03.00298103.CrossRefPubMed Dingli K, Coleman EL, Nennelle M, Finch SP, Wraith PK, Mackay TW, Douglas NJ: Evaluation of a portable device for diagnosing the sleep apnea/hypopnoea syndrome. Eur respir J. 2003, 21: 253-259. 10.1183/09031936.03.00298103.CrossRefPubMed
Metadata
Title
Autoadjusting-CPAP effect on serum Leptin concentrations in Obstructive Sleep Apnoea patients
Authors
Marta Drummond
João C Winck
João T Guimarães
Ana C Santos
João Almeida
José A Marques
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2008
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-8-21

Other articles of this Issue 1/2008

BMC Pulmonary Medicine 1/2008 Go to the issue